199 related articles for article (PubMed ID: 15757539)
1. [Expressions of 8-OH-dG, k-ras, and p53 genes in pleural effusion cells and their clinical significances].
Fu XY; Bin XN; Tan M
Ai Zheng; 2005 Mar; 24(3):345-8. PubMed ID: 15757539
[TBL] [Abstract][Full Text] [Related]
2. [Study of 8-OH-dG and its correlation with several cancer related gene in lung cancer tissues].
Lü J; Shi L; Wu Z; Liao Y; Zhou C; Li Y; Bin X; Zeng B; Chen J
Wei Sheng Yan Jiu; 2003 Jul; 32(4):304-7. PubMed ID: 14535088
[TBL] [Abstract][Full Text] [Related]
3. Detection of K-ras and p53 mutations in bronchoscopically obtained malignant and non-malignant tissue from patients with non-small cell lung cancer.
Lang SM; Stratakis DF; Freudling A; Ebelt K; Oduncu F; Hautmann H; Huber RM
Eur J Med Res; 2000 Aug; 5(8):341-6. PubMed ID: 10958767
[TBL] [Abstract][Full Text] [Related]
4. Expression and alteration of ras and p53 proteins in patients with lung carcinoma accompanied by idiopathic pulmonary fibrosis.
Takahashi T; Munakata M; Ohtsuka Y; Nisihara H; Nasuhara Y; Kamachi-Satoh A; Dosaka-Akita H; Homma Y; Kawakami Y
Cancer; 2002 Aug; 95(3):624-33. PubMed ID: 12209756
[TBL] [Abstract][Full Text] [Related]
5. High DNA damage by benzo[a]pyrene 7,8-diol-9,10-epoxide in bronchial epithelial cells from patients with lung cancer: comparison with lung parenchyma.
Rojas M; Marie B; Vignaud JM; Martinet N; Siat J; Grosdidier G; Cascorbi I; Alexandrov K
Cancer Lett; 2004 Apr; 207(2):157-63. PubMed ID: 15072824
[TBL] [Abstract][Full Text] [Related]
6. [Detection of oncogenic mutations in sputum and its diagnostic value of lung cancer].
Wang L; Wang G; Xia X
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Apr; 21(4):236-9. PubMed ID: 11326973
[TBL] [Abstract][Full Text] [Related]
7. GSTM1, P53 and K-ras molecular detection in resectable non-small cell lung cancer by denaturing gradient gel electrophoresis-bronchoalveolar lavage fluid analysis.
Curigliano G; Ferretti G; Mandalà M; De Pas T; Calabrò MG; Solli P; Noberasc C; de Braud F
Anticancer Res; 2001; 21(5):3461-9. PubMed ID: 11848510
[TBL] [Abstract][Full Text] [Related]
8. Expression of the p53 family in lung cancer.
Uramoto H; Sugio K; Oyama T; Nakata S; Ono K; Nozoe T; Yasumoto K
Anticancer Res; 2006; 26(3A):1785-90. PubMed ID: 16827107
[TBL] [Abstract][Full Text] [Related]
9. Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer.
Ferretti G; Curigliano G; Pastorino U; Cittadini A; Flamini G; Calabrò MG; De Pas T; Orlando L; Mandalà M; Colleoni M; Spaggiari L; Granone PL; Pagliari G; de Braud F; Fazio N; Goldhirsch A
Clin Cancer Res; 2000 Jun; 6(6):2393-400. PubMed ID: 10873091
[TBL] [Abstract][Full Text] [Related]
10. [A study on the role of DNA repair gene O6-methylguanine-DNA methyltransferase in the development of human lung cancer].
Lu JC; Shi LY; Wu ZL; Liao YD; Zhou S; Wang XY; Li YY; Bin XN; Zeng BH; Chen JK
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jan; 24(1):40-4. PubMed ID: 12678962
[TBL] [Abstract][Full Text] [Related]
11. 8-Hydroxy-2'-deoxyguanosine (8-OH-dG) as a potential survival biomarker in patients with nonsmall-cell lung cancer.
Shen J; Deininger P; Hunt JD; Zhao H
Cancer; 2007 Feb; 109(3):574-80. PubMed ID: 17154177
[TBL] [Abstract][Full Text] [Related]
12. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
[TBL] [Abstract][Full Text] [Related]
13. P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma.
Jassem J; Jassem E; Jakóbkiewicz-Banecka J; Rzyman W; Badzio A; Dziadziuszko R; Kobierska-Gulida G; Szymanowska A; Skrzypski M; Zylicz M
Cancer; 2004 May; 100(9):1951-60. PubMed ID: 15112277
[TBL] [Abstract][Full Text] [Related]
14. Detection of activated K-ras in non-small cell lung cancer by membrane array: a comparison with direct sequencing.
Chong IW; Chang MY; Sheu CC; Wang CY; Hwang JJ; Huang MS; Lin SR
Oncol Rep; 2007 Jul; 18(1):17-24. PubMed ID: 17549340
[TBL] [Abstract][Full Text] [Related]
15. K-ras and p53 mutations and overexpressions as prognostic factors in female rectal carcinoma.
Hirvikoski P; Auvinen A; Servomaa K; Kiuru A; Rytömaa T; Makkonen K; Kosma VM
Anticancer Res; 1999; 19(1B):685-91. PubMed ID: 10216477
[TBL] [Abstract][Full Text] [Related]
16. p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines.
Lehman TA; Bennett WP; Metcalf RA; Welsh JA; Ecker J; Modali RV; Ullrich S; Romano JW; Appella E; Testa JR
Cancer Res; 1991 Aug; 51(15):4090-6. PubMed ID: 1855224
[TBL] [Abstract][Full Text] [Related]
17. Relationship of p53 alteration and myc family gene overexpression with the clinical characteristics of lung cancer.
Bai L; Sun Y; Li S
Chin Med J (Engl); 1997 Apr; 110(4):250-4. PubMed ID: 9594222
[TBL] [Abstract][Full Text] [Related]
18. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
19. [Predicting efficacy of neoadjuvant cheomotherapy on resectable stage IIIA non-small cell lung cancer by multi-gene expressions].
Cheng C; Wu YL; Gu LJ; Chen G; Weng YM; Feng WN; Zhong WZ
Ai Zheng; 2005 Jul; 24(7):846-9. PubMed ID: 16004813
[TBL] [Abstract][Full Text] [Related]
20. Genetic alterations in K-ras and p53 cancer genes in lung neoplasms from Swiss (CD-1) male mice exposed transplacentally to AZT.
Hong HH; Dunnick J; Herbert R; Devereux TR; Kim Y; Sills RC
Environ Mol Mutagen; 2007; 48(3-4):299-306. PubMed ID: 16395694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
